 |
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1556307
線上人數 : 99
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/30612
|
| 題名: | Glutathione-S-trans ferase and p53 polymorphisms in cervical carcinogenesis |
| 作者: | Ueda, M;Hung, YC;Terai, Y;Saito, J;Nunobiki, O;Noda, S;Ueki, M |
| 貢獻者: | 醫學院醫學系婦產部;Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan;China Med Coll, Dept Obstet & Gynecol, Taichung, Taiwan;Kansai Med Coll, Dept Obstet & Gynecol, Osaka, Japan;Osaka Canc Prevent Ctr, Osaka, Japan |
| 日期: | 2005 |
| 上傳時間: | 2010-09-24 14:58:41 (UTC+8) |
| 出版者: | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| 摘要: | Objective. The purpose of this study was to examine whether interleukin-1 receptor antagonist (IL-1Ra) gene polymorphism is a marker of susceptibility to or of the clinical characteristics of gout in Taiwanese patients. Methods. 196 Taiwanese patients with gout and 103 unrelated normal healthy control subjects living in central Taiwan were studied. Polymorphism of the gene for IL-1Ra was typed from genomic DNA. Allelic frequencies and carriage rates were compared between gout patients and control subjects. The relationship between IL-1Ra genotypes and the clinical characteristics of gout was also evaluated. Results. No significant differences were observed in genetic and allelic frequencies of the IL-1Ra gene polymorphism between patients with gout and healthy control subjects. Furthermore, we did not detect any association of IL-1Ra genotype with the clinical and laboratory profiles in patients with gout. Conclusion. The results from the present study suggest that the interleukin-1 receptor antagonist gene polymorphism is not a genetic marker of susceptibility to gout for Taiwanese. Furthermore, our study also suggests that the IL-1Ra gene polymorphism is unrelated to the clinical characteristics of gout. |
| 關聯: | GYNECOLOGIC ONCOLOGY 96(3):736-740 |
| 顯示於類別: | [醫學系] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
